← All companies

LUNG

Pulmonx Corporation

LUNG Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$2.12

+0.51 +31.68%

Key statistics

from XBRL data in SEC filings

Market cap

$89.5M

Revenue (TTM)

$88.5M

Net income (TTM)

-$53.2M

EPS (TTM)

$-1.30

P/E ratio

—

Dividend yield

—

Free cash flow

-$32.8M

Cash

$61.6M

Total assets

$120M

Gross margin

75.5%

52-week range

$1.13 – $2.89

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Results of operations (earnings release) Jul 29, 2026 8-K Shareholder vote results Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release) Apr 29, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 5, 2026 8-K Results of operations (earnings release) Mar 4, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Results of operations (earnings release); Director or officer change Oct 27, 2025 10-Q Quarter ended 2025-06-30 Aug 1, 2025 8-K Results of operations (earnings release) Jul 30, 2025 8-K Shareholder vote results May 23, 2025 10-Q Quarter ended 2025-03-31 May 2, 2025 8-K Results of operations (earnings release) Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release) Feb 19, 2025 10-Q Quarter ended 2024-09-30 Nov 1, 2024 8-K Results of operations (earnings release) Oct 30, 2024 10-Q Quarter ended 2024-06-30 Aug 2, 2024 8-K Results of operations (earnings release) Jul 31, 2024 8-K Entered a material agreement May 23, 2024 8-K Shareholder vote results May 17, 2024 10-Q Quarter ended 2024-03-31 May 3, 2024 8-K Results of operations (earnings release) May 1, 2024 8-K Director or officer change; Other events Apr 2, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release) Feb 21, 2024 8-K Director or officer change; Other events Feb 21, 2024 10-Q Quarter ended 2023-09-30 Nov 3, 2023 8-K Results of operations (earnings release) Oct 30, 2023 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Oct 10, 2023 10-Q Quarter ended 2023-06-30 Aug 4, 2023 8-K Results of operations (earnings release) Aug 2, 2023 8-K Shareholder vote results May 18, 2023 10-Q Quarter ended 2023-03-31 May 8, 2023 8-K Results of operations (earnings release) May 2, 2023 10-K Fiscal year ended 2022-12-31 Mar 1, 2023 8-K Results of operations (earnings release); Took on a direct financial obligation Feb 22, 2023 10-Q Quarter ended 2022-09-30 Nov 8, 2022